Adaptive Biotechnologies Corporation

Washington
Pharmaceuticals Biotechnology and Life Sciences

Corprate Bias Ratings

Risk Level:

Rating - Caution
Medium Risk

Adaptive Biotechnologies Corporation vets vendors for LGBTQ policies and does not publish a nondiscrimination policy. However, it has not publicly terminated business relationships based on views or beliefs. The company covers the cost of "medically necessary transition-related care” for its employees and their children. However, it has not used its reputation or lobbying for ideological purposes. For these reasons, Adaptive Biotechnologies Corporation receives a Medium Risk rating.

Criteria
Risk Level
Rationale
Corporate Weaponization
Criteria

Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.

Risk Level
Rationale

Adaptive Biotechnologies has a written policy pledging to vet vendors for LGBTQ policies. Its Supplier Code of Conduct/Code of Business Ethics requires vendors to include sexual orientation and gender identity in their nondiscrimination policy (1). However, Adaptive Biotechnologies has not publicly terminated business relationships due to religious beliefs or political views.

Criteria

Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.

Risk Level
N/A
Rationale

Adaptive Biotechnologies does not publish charitable giving guidelines (1).

Criteria

Employment policies fail to protect against discrimination based on political affiliation/views and/or religion.

Risk Level
Rationale

Adaptive Biotechnologies does not publish a nondiscrimination policy (1).

Corporate Governance and Public Policy
Criteria

Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.

Risk Level
Rationale

Adaptive Biotechnologies has not supported ideological causes or policies (1).

Criteria

Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.

Risk Level
Rationale

Adaptive Biotechnologies’s HRC CEI profile indicates the company covers the cost of “medically necessary transition-related care” for its employees and their children (1)(2)(3).

Criteria

Uses corporate political contributions for ideological, non-business purposes.

Risk Level
Rationale

Adaptive Biotechnologies does not operate a PAC at this time and has not lobbied for ideological causes (1)(2)(3).

All links were last accessed and all information was updated on:
November 1, 2023

Company reports are intended for educational use only. Full Disclaimer

Generate Reports
Clear
Toast

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Privacy Policy.

Accept